Treatment of Anxiety and Depression with Venlafaxine

Introduction to Venlafaxine

The Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology recommends venlafaxine as a suggested treatment for social anxiety disorder, noting it is as effective and well-tolerated as first-line SSRIs 1, 2

The American College of Physicians notes that venlafaxine demonstrated superior response and remission rates compared to fluoxetine in one trial specifically for depression with prominent anxiety symptoms 3
Allow 6-8 weeks for adequate trial before dose adjustment, as recommended by clinical guidelines 3
For patients with depression plus anxiety symptoms, starting venlafaxine XR 75 mg daily and titrating to 150-225 mg daily addresses both conditions simultaneously, as treating depression often improves comorbid anxiety 4

Consider venlafaxine XR if inadequate response to SSRIs after 6-8 weeks, as suggested by clinical guidelines 3, 4
Monitor for treatment-emergent suicidality, particularly in patients under age 24, especially in the first 1-2 weeks, and consider alternative agents for patients with comorbid hypertension or cardiovascular concerns 3, 4